4//SEC Filing
Weiser Jorg 4
Accession 0001209191-21-021828
CIK 0001490978other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:46 PM ET
Size
24.2 KB
Accession
0001209191-21-021828
Insider Transaction Report
Form 4
Weiser Jorg
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-03-16$4.34/sh+6,527$28,327→ 169,943 total - Sale
Common Stock
2021-03-16$82.00/sh−6,527$535,214→ 163,416 total - Exercise/Conversion
Common Stock
2021-03-16$3.07/sh+18,095$55,552→ 181,511 total - Sale
Common Stock
2021-03-16$82.00/sh−37,060$3,038,920→ 126,356 total - Sale
Common Stock
2021-03-17$78.07/sh−6,600$515,277→ 119,756 total - Sale
Common Stock
2021-03-17$79.70/sh−1,500$119,548→ 118,256 total - Sale
Common Stock
2021-03-17$81.33/sh−300$24,399→ 117,052 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-16−18,095→ 0 totalExercise: $3.07Exp: 2026-05-10→ Common Stock (18,095 underlying) - Sale
Common Stock
2021-03-17$80.85/sh−904$73,087→ 117,352 total - Sale
Common Stock
2021-03-16$82.00/sh−18,095$1,483,790→ 163,416 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-16−6,527→ 9,614 totalExercise: $4.34Exp: 2028-11-29→ Common Stock (6,527 underlying)
Holdings
- 17,390(indirect: BY ANTERIO CONSULT AND RESEARCH GMBH)
Common Stock
Footnotes (7)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.73 to $78.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.25 to $80.18, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.32 to $81.31, inclusive.
- [F5]The shares are beneficially owned by Anterio Consult & Research GmbH ("Anterio"). Dr. Weiser is a shareholder and former managing director of Anterio and disclaims beneficial ownership of the shares held by Anterio, except to the extent of his pecuniary interest therein, if any.
- [F6]The option was granted on May 11, 2016 and is fully vested.
- [F7]This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
Documents
Issuer
Schrodinger, Inc.
CIK 0001490978
Entity typeother
Related Parties
1- filerCIK 0001797782
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:46 PM ET
- Size
- 24.2 KB